Olema Pharmaceuticals OLMA
NASDAQ OLMA
$7.22 -0.05 (-0.62%)
As of: Nov 11, 2026 · 10:42 AM EST

Olema Pharmaceuticals (OLMA) Non Operating Interest Expenses (2020)

Updated

Olema Pharmaceuticals' Non Operating Interest Expenses was $653,000 in FY2020.

Analysis

Olema Pharmaceuticals (OLMA) Non Operating Interest Expenses (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Olema Pharmaceuticals 734.94 Mn -1.15 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 653,000.00
API Access

Olema Pharmaceuticals Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=OLMA&period=max&api_key=YOUR_API_KEY